Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Amplia Therapuetics Limited
Amplia Therapeutics Reports Four Additional Complete Responses and Improved Overall Survival Data in Accent Pancreatic Cancer Trial
May 19, 2026
Poster Presentation Demonstrating Combination Benefit of Narmafotinib in Preclinical Kras-Mutated Cancer Models
May 18, 2026
Amplia Therapeutics – Quarterly Activities and Cash Flow Reports – December 2025
January 30, 2026
NARMAFOTINIB Large-Scale Manufactre Complete
January 22, 2026